Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars
The Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weight-loss drugs.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.marketwatch.com — the content belongs to MarketWatch.